[go: up one dir, main page]

ATE364328T1 - Rehydratisierungs-zusammensetzung - Google Patents

Rehydratisierungs-zusammensetzung

Info

Publication number
ATE364328T1
ATE364328T1 AT02711526T AT02711526T ATE364328T1 AT E364328 T1 ATE364328 T1 AT E364328T1 AT 02711526 T AT02711526 T AT 02711526T AT 02711526 T AT02711526 T AT 02711526T AT E364328 T1 ATE364328 T1 AT E364328T1
Authority
AT
Austria
Prior art keywords
fluid
rehydration composition
relates
rehydration
composition
Prior art date
Application number
AT02711526T
Other languages
English (en)
Inventor
Robert Johan Joseph Hageman
George Verlaan
Rudolf Smeets
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE364328T1 publication Critical patent/ATE364328T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02711526T 2001-01-26 2002-01-28 Rehydratisierungs-zusammensetzung ATE364328T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/770,773 US20020176881A1 (en) 2001-01-26 2001-01-26 Rehydration composition

Publications (1)

Publication Number Publication Date
ATE364328T1 true ATE364328T1 (de) 2007-07-15

Family

ID=25089632

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06076906T ATE551911T1 (de) 2001-01-26 2002-01-28 Rehydratisierungszusammensetzung
AT02711526T ATE364328T1 (de) 2001-01-26 2002-01-28 Rehydratisierungs-zusammensetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06076906T ATE551911T1 (de) 2001-01-26 2002-01-28 Rehydratisierungszusammensetzung

Country Status (9)

Country Link
US (3) US20020176881A1 (de)
EP (2) EP1762271B1 (de)
AT (2) ATE551911T1 (de)
AU (1) AU2002230270B2 (de)
CA (1) CA2436764C (de)
DE (1) DE60220640T2 (de)
DK (1) DK1353726T3 (de)
ES (1) ES2286238T3 (de)
WO (1) WO2002058792A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7740878B2 (en) * 2001-10-22 2010-06-22 Danisco A/S Use of betaine to enhance exercise performance
DE10214168A1 (de) * 2002-03-27 2003-10-09 Siegfried Irion Coffeinhaltiges Getränkeerzeugnis
US7850989B2 (en) * 2003-06-12 2010-12-14 Provimi North America, Inc. Critical care for neonatal calves
DE20312929U1 (de) * 2003-08-18 2003-10-23 Donhuysen, Sven, 47800 Krefeld Energiegetränk
US7527816B2 (en) * 2004-08-06 2009-05-05 Techmix, Inc. Feed supplement and method
FR2913338B1 (fr) * 2007-03-06 2009-07-24 Aditec Soc Par Actions Simplif Composition de rehydratation.
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US8187647B2 (en) 2008-06-13 2012-05-29 BioClinical Development, Inc. Edible energy composition
PT2214521T (pt) * 2007-11-16 2019-03-29 Int Ip Holdings Llc Composição energética comestível com baixo teor de cafeína
US9017748B2 (en) * 2007-12-28 2015-04-28 Kraft Foods Group Brands Llc Potassium fortification in foodstuffs
EP2098124A1 (de) 2008-03-03 2009-09-09 Nestec S.A. Kohlenhydratgel
US20090286750A1 (en) * 2008-05-16 2009-11-19 Kasubick Robert V Use of ribose in lessening the clinical symptoms of aberrant firing of neurons
CA2723441A1 (en) * 2008-05-21 2009-11-26 Stokely-Van Camp, Inc. Milk-based recovery beverage
US9049879B2 (en) 2008-06-13 2015-06-09 International Ip Holdings Llc Edible energy composition
US10881661B2 (en) 2008-06-13 2021-01-05 International Ip Holdings Llc Edible energy composition
EP2461707A4 (de) * 2009-08-04 2013-08-28 Northforce Oy Trinkzusammensetzung
AU2012242565B2 (en) 2011-04-13 2017-05-11 Thermolife International, Llc N-Acetyl Beta Alanine methods of use
US8557301B2 (en) 2011-07-01 2013-10-15 Drip Drop, Inc. Oral rehydration composition
JP5695688B2 (ja) * 2013-03-08 2015-04-08 サントリー食品インターナショナル株式会社 飲料
US10653168B2 (en) 2013-06-12 2020-05-19 Sweetwater Solutions, LLC Oral rehydration solution with improved taste
US20180064154A9 (en) * 2015-09-01 2018-03-08 D. Holmes Morton Management of propionate metabolism disorders
US20170360074A1 (en) * 2016-06-17 2017-12-21 Krampade, LLC Consumable electrolyte compositions and methods of use thereof
CN106071540A (zh) * 2016-06-17 2016-11-09 山东祥维斯生物科技股份有限公司 运动型保健减肥饮料及其制备方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US10820617B1 (en) 2018-03-29 2020-11-03 Government Of The United States, As Represented By The Secretary Of The Air Force All inclusive electrolytes, vitamins, and protein powder training supplement
US20210299166A1 (en) * 2020-03-25 2021-09-30 Allgood Beverage Company Compositions for maintaining electrolyte balance and urinary tract health
JP2024541338A (ja) 2020-11-12 2024-11-08 サーモライフ インターナショナル, エルエルシー 血中酸素飽和度を増大させる方法
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
CA3206079A1 (en) 2021-02-11 2022-08-18 Ronald Kramer A method of administering nitric oxide gas
US20220306975A1 (en) * 2021-03-29 2022-09-29 Jho Intellectual Property Holdings, Llc Electrolyte-containing alcoholic beverages
WO2025183662A1 (en) * 2024-02-26 2025-09-04 Kozlovskyi Vadym Oleksiiovych Electrolyte solution
US12440512B1 (en) * 2024-12-08 2025-10-14 Iv Nector Md Systems and methods for preparing and administering a hydrating supplement composition

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE427983B (sv) * 1980-02-15 1983-05-30 Pripps Bryggerier Ab Dryckesprodukt
US4631189A (en) * 1980-03-10 1986-12-23 Da Vinci Laboratories, a division of FoodScience Corporation N,N-dimethylglycine and use in immune response
US5017389A (en) * 1988-08-16 1991-05-21 Green Scott T Nutritional drink compositions
US5032411A (en) * 1990-02-27 1991-07-16 University Of Texas System Board Of Regents Beverage compositions for human consumption
US5114723A (en) 1990-02-27 1992-05-19 University Of Texas System Board Of Regents Beverage compositions for human consumption
AU7584891A (en) * 1990-03-19 1991-10-21 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
US5182299A (en) * 1990-03-19 1993-01-26 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5498408A (en) * 1992-09-21 1996-03-12 Sandoz Nutrition Ltd. Oral rehydration composition
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink
US5389383A (en) * 1993-06-18 1995-02-14 Allergan, Inc. Method for treating hypoxia-associated ocular complications
US5464619A (en) * 1994-06-03 1995-11-07 The Procter & Gamble Company Beverage compositions containing green tea solids, electrolytes and carbohydrates to provide improved cellular hydration and drinkability
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
AU3570495A (en) * 1994-09-22 1996-04-09 Quadrant Holdings Cambridge Limited Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
US6020139A (en) * 1995-04-25 2000-02-01 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
EP0875155A1 (de) * 1997-05-01 1998-11-04 N.V. Nutricia Perioperatives Getränk
EP0891719A1 (de) * 1997-07-14 1999-01-20 N.V. Nutricia Narungszusammensetzungen mit Gehalt an Methionin
GB9715340D0 (en) * 1997-07-22 1997-09-24 Cerestar Holding Bv Beverages for enhanced physical performance
US5972985A (en) * 1997-11-03 1999-10-26 Cytos Pharmaceuticals, Llc Histidine containing nutriceutical compositions
US5891888A (en) * 1998-01-14 1999-04-06 Strahl; Robert Charles Physical endurance drink
EP1124559B1 (de) * 1998-10-30 2003-03-26 MERCK PATENT GmbH Zusammensetzung zur behandlung und prävention neurologischer und pathopsychologischer krankheiten
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
US8697679B2 (en) * 2003-03-07 2014-04-15 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress

Also Published As

Publication number Publication date
EP1762271B1 (de) 2012-04-04
ATE551911T1 (de) 2012-04-15
EP1353726B1 (de) 2007-06-13
CA2436764A1 (en) 2002-08-01
EP1762271A3 (de) 2007-06-27
EP1762271A2 (de) 2007-03-14
EP1353726A2 (de) 2003-10-22
US7375089B2 (en) 2008-05-20
WO2002058792A3 (en) 2002-11-21
WO2002058792A8 (en) 2003-11-06
AU2002230270B2 (en) 2006-05-04
CA2436764C (en) 2011-03-29
US20020176881A1 (en) 2002-11-28
ES2286238T3 (es) 2007-12-01
WO2002058792A2 (en) 2002-08-01
DE60220640T2 (de) 2008-02-21
US20040087518A1 (en) 2004-05-06
DK1353726T3 (da) 2007-10-15
DE60220640D1 (de) 2007-07-26
US20080193589A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
DE60220640D1 (de) Rehydratisierungs-zusammensetzung
BR0211390A (pt) Tratamento de infecções da unha com no
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
ECSP045154A (es) Composiciones de fórmula para infantes que comrende cantidades aumentadas de alfa - lactalbumin
AU3113902A (en) Thiazolyl inhibitors of tec family tyrosine kinases
DK1988397T3 (da) Præparater og anvendelser til stabilisering af transthyretin og inhibering af transthyretin-fejlfoldning
NO20033687L (no) Hydraulisk fraktureringsfluid omfattende en blokk-kopolymer inneholdende minst en vannopplöselig blokk og en hydrofob blokk
ATE359753T1 (de) Absorbierender artikel mit grössenanpassung
BR0104654A (pt) Artigo absorvente
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
NO972538L (no) Nye sulfonamider
PT1149092E (pt) 4- e 5-alciniloxindois e 4- e 5-alceniloxindois
BR0206639A (pt) Combinações de inibidor(es) da absorção do esterol com modificador(es) do sangue para o tratamento de condições vasculares
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
CY1108078T1 (el) Παραγωγα του ν-θειο-νικοτιναμιδιου και συγγενεις ενωσεις για χρηση ως παρασιτοκτονα
BRPI0414215A (pt) tienopirazóis
ATE291424T1 (de) Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung
DE50209015D1 (de) NEUE VERWENDUNG VON 2-Ä2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenylÜ-5-methyl-7-propyl-3H-imidazoÄ5,1-fÜÄ1,2,4Ütriazin-4-on
BR0208694A (pt) Uso de inibidores de cox-2 seletivos para tratamento de incontinência urinária
DK1269859T3 (da) Anvendelse af middelkædede triglycerider til forebyggelse og terapi af adipositas
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
MXPA03000313A (es) Uso de fosfato de estramustina en el tratamiento de metastasis osea.
HRP20050611B1 (hr) Kombinacijski lijek
DE50001900D1 (de) Spritze

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1353726

Country of ref document: EP